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ABSTRACT
Alternative splicing is an important regulatory
mechanism of mammalian gene expression. The
alternative splicing database (ASD) consortium is
systematically collecting and annotating data on
alternative splicing. We present the continuation
and upgrade of the ASD [T. A. Thanaraj, S. Stamm,
F. Clark, J. J. Riethoven, V. Le Texier, J. Muilu (2004)
NucleicAcidsRes.32,D64–D69]thatconsistsofcom-
putationally and manually generated data. Its largest
parts are AltSplice, a value-added database of com-
putationallydelineatedalternativesplicingevents.Its
data include alternatively spliced introns/exons,
events,isoformsplicingpatternsandisoformpeptide
sequences. AltSplice data are generated by examin-
ing gene-transcript alignments. The data are annot-
atedforvariousbiologicalfeaturesincludingsplicing
signals, expression states, (SNP)-mediated splicing
and cross-species conservation. AEdb forms the
manually curated component of ASD. It is a
literature-based data set containing sequence and
properties of alternatively spliced exons, functional
enumeration of observed splicing events, character-
ization of observed splicing regulatory elements, and
a collection of experimentally clarified minigene con-
structs. ASD includes a workbench, which is an ana-
lysis tool that enables users to carry out splicing
related analysis such as characterization of introns
for various splicing signals, identification of splicing
regulatory elements on a given RNA sequence, pre-
diction of putative exons and prediction of putative
translation start codons. The different ASD modules
are integrated and can be accessed through user-
friendly interfaces and visualization tools. ASD data
has been integrated with Ensembl genome annota-
tion project as a Distributed Annotation System
(DAS) resource and can be viewed on Ensembl
genome browser. The ASD resource is presented at
(http://www.ebi.ac.uk/asd).
INTRODUCTION
Alternative pre-mRNA splicing is emerging as one of the most
important mechanisms to control eukaryotic gene expression.
Recent array data indicate that as much as 76% of genes
generate alternatively spliced products (1). Alternative spli-
cing regulates numerous aspects of protein function, such as
binding properties, intracellular localization, enzymatic activ-
ity, stability and post-translational modiﬁcations. Reports in
literature indicate that protein isoforms generated by altern-
ative splicing show in most cases only subtle differences.
However, in some cases alternative splicing can lead to
large functional differences, e.g. by generating dominant
negative isoforms (2). Finally, 10–15% of genes could be
switched off due to the coupling between nonsense-
mediated decay and alternative splicing (3). This indicates
that alternative splicing controls both transcript composition
and abundance.
Despite intense research, the mechanisms leading to
splice site selection are not fully understood. Currently, it is
not possible to accurately predict alternative exons from
genomic sequences. It is not at all possible to predict the
tissue or developmental expression proﬁle of an alternative
exon. The major obstacle for an accurate prediction is the
lack of conservation in the regulatory sequences of the pre-
mRNA that can only be described by consensus sequences or
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doi:10.1093/nar/gkj031expectation matrices. However, in vivo, alternative exons are
recognized and regulated with high ﬁdelity, because numerous
proteins bind to pre-mRNA and help in exon recognition. Due
to the combination of multiple weak protein–protein and
protein–RNA interactions, alternative exons can be faithfully
recognized (4,5).The importance of proper splicing site recog-
nition is underlined by an increasing number of diseases that
are caused or associated with the selection of wrong splicing
sites (6,7).
Alternative splicing events have been compiled previously
in different databases [reviewed in (8)]. Here, we present the
continuation and upgrade of the alternative splicing database
(ASD) [the previous version was reported earlier in (9)] as a
bioinformatics resource that integrates data on alternative spli-
cing, derived from computational as well as literature based
approaches, and bioinformatics analysis tools.
ASD
The different component data sets of ASD
Data generated from computational approaches and data
reported in the literature are the two major sources for data-
bases on alternative splicing. The major advantage of data
from computational approaches, such as EST comparison,
is the large size of the data sets. However, these data sets
lack biological information about the alternative splicing
events. In contrast, data sets derived from the literature contain
biologically relevant information, but these data sets are smal-
ler. In order to combine these two approaches, we carried out
two activities namely, (i) we developed a computational pipe-
line (AltSplice) that generates genome-wide value-added data
on alternative exons, and (ii) we developed a procedure
(AEdb) that manually collects data on alternative exons
from literature. In addition, data on motifs, functions and
minigenes described in the literature were collected in data-
bases. We then built an integrated database (Figure 1) from
these heterogeneous data resources. The integrated database is
named ASD for which we developed query interfaces that are
ﬂexible enough to handle the heterogeneity. A single-query
bar provides a quick access to all of ASD data, allowing
retrieval of datausingkeywordsearchorsequencecomparison
searches. In addition, each data set can be queried using a data
set-speciﬁc interface. Finally, all data sets can be downloaded
as ﬂat ﬁle distributions.
The statistics on different data sets of the ASD are listed in
Table 1.
AltSplice. AltSplice data are generated by an automated
computational pipeline. The basal data includes transcript-
conﬁrmed introns/exons, alternative splicing events and iso-
form splicing patterns. The basal data are generated through
computational comparison of EST/mRNA alignments with
genomicsequences [see(9,10) fordetails onthecomputational
Figure 1. StructureofASD.Weusedcomputationalpipelinesandmanualcuration(top,pink)tocreatethemodulardatabasesofASD(middle,blue).Theindividual
databases are integrated, cross-linked and are available through a variety of interface tools (bottom, sky blue). Currently the databases are the computer generated
Altsplice and the manually-curated AEdb-Sequence, AEdb-Motif, AEdb-Function and AEdb-Minigene databases. The ASD data are integrated with Ensembl
genomeannotationsystemandisvisiblefromEnsemblgenomebrowser;Publicly-availabledatabasesonalternativesplicingareaccessiblefromASDinterfaces(top
right, dark green) The databases are connected to analysis tools that are collected in the ASD workbench (middle right, grey).
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as splicing site characteristics, expression state of the iso-
forms, allele usage at SNP positions, conservation of intron/
exon-events across species and peptide isoforms) by various
computational modules that are part of AltSplice pipeline.
AltSplice data (Table 1) indicates that up to 61% of human
genes (and 50% of mouse genes) undergo alternative splicing.
The available transcriptome data indicates that in an average
3.9 isoform splicing patterns can be expressed from a single
human gene. Cassette exon events outnumber the other event
Table 1. Statistics on ASD data
AltSplice data statistics (Release 2 of AltSplice-Human and AltSplice-Mouse)
Genes with alternative splicing 9929 (61%) of 16293 human genes
8211 (50%) of 16391 (mouse) genes
Alternative splicing events per gene 2.6 (human); 2.2 (mouse)
Alternative splicing patterns per gene 3.9 (human); 3.7 (mouse)
Distribution of the observed event types Cassette exon (52%)
Alternate acceptor or donor (27%)
Intron retention (17%)
Mutually exclusive (4%)
Flanking exons often undergo extension or truncation 26% of Cassette exon events
23% of Retained introns
19% of Mutually exclusive exons
Human-mouse conservation Orthologous gene pairs ¼ 5176
Number of conserved events ¼ 1177
Number of conserved exons ¼ 28276
Entries with peptide sequence annotation for at least 1 splicing pattern 6848 (human); 4366 (mouse)
Entries with peptide sequence annotation for >2 splicing patterns 2896 (human); 977 (mouse)
Entries for which variant peptide data are available in UniProt 2083 (human); 896 (mouse)
Entries presenting data for >2 isoform peptide sequences
(by either of the above two sources)
3994 (human); 1573 (mouse)
Entries associated with AEdb-Sequence database 367 (human); 118 (mouse)
AEdb-Sequence data statistics-2255 entries
Distribution Number of entries
Organism distribution Human (1283); mouse (413); rat (232); drosophila (100); others (227)
Event type distribution Cassette exon (1281)
Alternative acceptor or donor (395)
Intron retention (154)
Mutually exclusive exons (130)
Alternative 30 exon by polyA variant (71)
Regulation associated with disease 295
Regulation associated with development 282
Regulation associated with tissue type 312
Regulation causing frameshift 151
Regulation introducing stop codons 260
Alternative exon being noncoding exon 222
Entries associated with AltSplice 1198 (human and mouse entries)
AEdb-Function data statistics-354 entries
Functional role Number of entries
Modulation of protein interaction 136
Internal structural change 119
Novel carboxyl terminus 87
Novel amino terminus 38
Association with disease 81
Intracellular location 76
Enzymatic activity 64
Channel activity 54
Others 37
AEdb-Motif data statistics-255 entries
Type of regulator sequence Number of entries
Exon enhancer 97
Exon silencer 44
Intron enhancer 56
Intron silencer 37
AEdb-Minigene data statistics—82 entries
Distribution Number of entries
Organism distribution Human (46); mouse (17); rat (15); others (9)
Splicing mechanism distribution Cassette exon [single exon, 45; multiple casette exons (3);
incremental combinatorial exons (2)]; Alternative acceptor or
donor sites (17); Mutually exclusive exons (13); Intron retention (2)
Reported tissue specificity 55
Known regulatory factors 32
Deduced enhancer and silencer sequences 97
Hyperlinks to AEdb-Sequence database 78 (to 105 AEdb-Sequence entries)
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panied by extension/truncation of the ﬂanking exons. The
number of human-mouse orthologous gene pairs (with data
on alternative splicing) present in AltSplice is around 5200,
and such a large data set is valuable for studies on evolution
of alternative splicing. Finally, AltSplice presents data on
isoform peptide sequences for around 4000 human genes,
and such a large data set of variant peptides is valuable for
studies aimed at deciphering splicing mediated functional and
structural changes in proteins.
AEdb-Sequence. AEdb-Sequence is a literature based, manu-
ally curated database of alternative exons. We used ‘alternat-
ive splicing’ as a keywordto search PubMed bibliography data
and collected information on the following features from the
resultant research articles: organism, splicing mechanism,
tissue-speciﬁcity, regulation during development stages, dis-
ease association, regulatory features of the exon and the
sequence of the alternatively spliced exon as well as its ﬂank-
ing constitutive exons. It is seen that more than half the num-
ber of AEdb-Sequence entries are from human (Table 1). As is
in the case of AltSplice data, cassette exon events outnumber
other event types. The data set reports splicing events that are
speciﬁc to cellular states, such as tissue type, development
stage and disease state. Roughly 10% of the entries report
events that introduce premature stop codons and this data
set can serve the studies on nonsense mediated decay of tran-
scripts. Finally, 10% of the reported exons are from non-
coding regions of the genes.
AEdb-Function. The function database is a literature based,
manually curated database of known functions of the altern-
ative exons. Functional differences between the protein iso-
forms generated by alternative splicing are enumerated from
the literature and are organized into 11 well-deﬁned categor-
ies, such as ‘Modulation of protein interaction’ or ‘Internal
structural change’ (Table 1). An analysis of the function of
alternative exons based on this data set has been published
previously (2).
AEdb-Motif. Alternative splicing site selection is partially
regulated by weak binding of proteins to highly degenerate
regulatory sequences. As a ﬁrst attempt to understand the
combinatorial control behind this regulation, we collected
splicing regulatory motifs described in literature and expanded
upon the previous collections of intronic regulatory sequences
(11), exonic regulatory sequences (12,13) and disease-causing
mutations (6). The collection reports 153 enhancer sequences
and 81 silencer sequences (Table 1). The entries are annotated
with value-added information, such as the experimental tech-
nique used, the nucleotide sequence of the motif, mutations
that are studied and the protein that binds at the motif.
AEdb-Minigenes. A minigene is a genomic fragment that
includes the alternative exon and the surrounding introns as
well as the ﬂanking constitutively spliced exons. Constructs
derived by cloning the insert in an eukaryotic expression vec-
tor are increasingly used to study alternative splicing (14,15).
We compiled all minigenes described in the literature. The
splicing patterns and deduced regulatory sequences are rep-
resented in a graphic format. The minigene collection includes
82 entries for which a total of 97 regulatory sequences are
ascribed. The reported minigene constructs representing
cassette exon events outnumber those for other event types
(Table 1). The minigene entries are linked to appropriate
entries in AEdb-Sequence data set, which allows the user to
quickly identify experimentally useful minigenes by searching
the database.
DATA INTEGRATION
Integration of data across the different data sets of ASD
Extensive integration has been made between AltSplice and
AEdb-Sequence. Alternative exons and events that are com-
mon in AltSplice and AEdb-Sequence are identiﬁed and are
annotated in both the databases. This allows associating the
manually-collected annotations to the computationally gener-
ated data in AltSplice. Related entries among AEdb-Sequence,
-Function and -Minigenes are identiﬁed and are annotated.
Table 1 shows that from the 1700 AEdb-Sequence entries,
as much as 1200 are associated with AltSplice entries; and
as much as 78 of 82 entries from AEdb-Minigenes data set are
associated with AEdb-Sequence data set.
Integration with other resources
Ensembl (16) and UniProt (17) are among the most important
resources on sequence data. Both include signiﬁcant data relat-
ing to alternative splicing, e.g. Ensembl reports alternative
transcripts while UniProt reports curated data on isoform
peptide sequences. AltSplice uses Ensembl genes as the start-
ing gene set for deriving splicing patterns. Therefore, the
AltSplice data are intrinsically associated with Ensembl
annotation of alternate transcripts and related information.
Data on peptide variants collected in UniProt are integrated
with AltSplice and they complement the set of AltSplice-
derived peptide isoform data.
ACCESS TO DATABASES
ASD interfaces
ASD contains heterogeneous data sets—AltSplice is created
through computational analysis of gene-transcript alignments,
and AEdb is created by manual curation of literature data.
Furthermore, there are differences in the extent of annotation
and in the adopted vocabularies. We therefore generated inter-
faces that are ﬂexible enough to handle this heterogeneity and
that allow an easy retrieval of information. Different layers of
interfaces are available and they provide either a single-point
access to all the data sets or advanced searches of individual
data sets.
Single-querybarandwrapperinterfaces.Both theseinterfaces
provide aquickaccesstoallofASD data. The single-querybar
accepts commonly-used search terms, such as keywords, gene
symbols (or their synonyms) and database cross-references.
The wrapper interface queries all of ASD data against a given
search term; these terms include the above-mentioned com-
monly used terms and splicing event type. Queries can be
selectively restricted to speciﬁc sets of gene entries, such as
set of human-mouse orthologous gene pairs or set of gene
Nucleic Acids Research, 2006, Vol. 34, Database issue D49entries for which data on isoform peptide sequences is avail-
able or integrated set of AltSplice-AEdb entries.
Advanced search query interfaces. The individual data sets
differ in terms of the type of data and annotation—e.g.
AltSplice reports splicing events, splicing patterns and
introns/exons while AEdb-Motif reports splicing regulatory
sequences. Thus specialized query interfaces have been
built for individual data sets.
Interface for AltSplice. Genes can be queried by chromosomal
location, gene names and synonyms, protein keywords and
database cross-references [such as EMBL (18) and UniProt
accession nos (17), HUGO gene symbols (19), Gene Ontology
identiﬁers (20) and protein identiﬁers], types of splicing events
and allele speciﬁcity at SNP positions. Browsers allowing
selection of eVOC standard vocabularies for EST library
annotation (21) and GO classiﬁers facilitate querying through
expression states and through protein function/process/loca-
tion. Queries can be selectively restricted to speciﬁc sets of
gene entries, such as to the set of human-mouse orthologous
gene pairs, or to the set of gene entries for which data on
isoform peptide sequences is available, or to the integrated
set of AltSplice-AEdb entries. A particularly useful query for
experimentalists is ’Library Subtraction Tool’, which let users
retrieve gene entries with splicing patterns that are differen-
tially expressed in different cell states.
Interface for AEdb-Sequence. The data can be queried by gene
names and synonyms, database cross-references, type of spli-
cing events and type of regulatory roles, such as introducing
premature termination codons or frameshifts. Further, the data
can be queried for disease association and developmental
speciﬁcity.
Interface for AEdb-Function. The data can be queried by gene
names, protein keywords and database cross-references.
Further, queries based on the functional enumeration of the
isoform peptide sequence can be raised by selecting from a
predeﬁned list of functional categories (for the list of
functional categories see Table 1).
Interface for AEdb-Motif. The interface allows free-text
search. The search items include gene names, sequence of
Figure 2. ResultpageofquerytoallofASDdata.TheASDwasqueriedusingthewrapperinterfacewiththeterm‘tra2a*|tra2b*’andthisresultedintheretrievalof
data entries from AltSplice-Human (two entries), AEdb-Sequence (seven entries),AEdb-Function (one entry) and AEdb-Motif(five entries). This figure illustrates
the integration among the different data sets of ASD—(i) the AltSplice-Human entries are seen associated with entries from AEdb-Sequence, and from AltSplice-
Mouse; (ii) the AEdb-Sequence entries are seen associated with entries from AltSplice-Human. These associations are hyperlinked.
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cer or silencer).
BLAST and FASTA searches to ASD. The nucleotide and
peptide sequences from ASD can be searched through
both BLAST (WU-BLAST2) (http://blast.wustl.edu) and
FASTA utilities (22). The objective of these search
programs is to identify sequence similarities between novel
sequences and alternatively spliced sequences collected
in ASD. BLAST reports regions of high similarity. FASTA
can be very useful to identify long regions of low similar-
ity between highly diverged sequences. Further, FASTA
is helpful when the query sequence is short, since
BLAST usually fails to report results for short query
sequences.
One-stop query system to access publicly available databases
on alternative splicing. Several databases on alternative
splicing are publicly available. To facilitate extraction of all
known information about splicing of a gene, we generated a
single interface that queries various databases simultaneously.
Presently, seven alternative splicing databases namely, ASD,
ASG, PALS, SpliceInfo, MAASE and HASDB (23–27) are
made available from this interface. The interface accepts
typical search terms (such as keywords, gene names and
cross-references) and queries all these databases. The results
(c)
Figure 3. Displayofdataonalternativesplicingofhumantra2-betageneasseeninAltSpliceandAEdb-Functiondatasets.(a)Thisfigurepresentsadisplayofdata
sectionsonGeneInformation,EvidencesandSplicingeventsasseeninAltSplice.Geneinformationsectionprovideshyperlinkstoapagelistingthegeneentryfrom
HUGO Gene Nomenclature database and to a page which lists the sequence of the gene. The evidences section provides hyperlinks to the associated entries from
AEdb-Sequence,topagesthatlistvariantpeptidesequencesforthegenefromUniProtortopagesthatlisttheEnsembltranscriptsequencesforthegene.Theevents
section lists all the splicing events that AltSplice has identified for the gene. Column 1 lists the gene coordinates of alternatively spliced exons/introns. Column 2
indicateswhethertheeventinvolvesmodificationsintheflankingexonsaswell;entriesarehyperlinkedtopageslistingdetailedinformationontheevent.Column3
indicatestheidentifieroftheassociatedentryfromAEdb-Sequence(ifany)andtheentryishyperlinked.Column4indicatestheidentifieroftheorthologousgene(if
any)andthecoordinatesoftheexonorthologoustotheonepresentedincolumn1;theentryishyperlinkedtotheorthologousgeneentry.(b)Thisfigurepresentsthe
textualandgraphicaldisplayofobservedsplicingpatternsfortra2-betageneasseeninAltSplicedata.SplicePatternTable:Entryincolumn1ishyperlinkedtoapage
listingthesequenceofthesplicingpattern.Entryincolumn2givesthecodingstartandendpositionsonthegeneandthelengthofthetranslatedpeptidesequenceand
ishyperlinkedtoapagelistingthepeptidesequence.Entryincolumn3liststhestructureofthesplicingpatternasastringofexons(exonboundariesarepresentedin
genecoordinates).Entryincolumn4ishyperlinkedtopageslistingdetailedinformationontheconfirmingtranscriptsequences.Entryincolumn5ishyperlinkedto
pageslistingexpressionstates.Entryincolumn6ishyperlinkedtopageslistingallelespecificityofthesplicingpattern.SplicePatternView:Exonsareindicatedby
boxes and introns by lines. Exons/introns that are variants are indicated in blue color. Browsing the cursor over various elements of the pattern displays pop-up’s
giving detailed information on the elements. The displayed pop-up in this example shows information on the expression state of Splicing Pattern 6. (c) This figure
presents data on the functionalchanges due to alternative splicingin tra2-beta asseen in AEdb-Function data set. The data are organisedinto three sectionsnamely,
gene information, bibliography information and functional information. This figure illustrates the wealth of knowledge captured from literature.
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presented with hyperlinks to the individual databases.
Example of data search and of data content
Figures 2 and 3 illustrate the results of searching the database
for all entries of tra2-alpha and tra2-beta, two important spli-
cing regulators. Querying the ASD using wrapper query inter-
face for ‘tra2a* | tra2b*’ as keyword produces an output page
(Figure 2) that lists entries from the different component data
sets. As can be seen from the ﬁgure, related data entries across
thedifferentdatasetsarehyperlinkedtooneanother.Figure3a
and b illustrate the presentation of some of the data items from
AltSplice for tra2-beta; Figure 3a shows sections on gene
information, on evidences for alternative splicing of tra2-
beta, and on the observed splicing events in AltSplice.
Figure 3b shows splicing patterns presented in textual form
(as Splice Pattern Table) and in graphical form (as Splice
Pattern view). Individual data items in the display page are
hyperlinked to pages that list detailed information. For
example,thesplicingpatternentrynumberinthetableislinked
to a page that lets the user to perform multiple alignments on
the sequences of all the observed isoform splicing patterns or
peptides. Figure 3c shows the display page of tra2-beta entry
from AEdb-Function data set; it illustrates the wealth of
information that is captured from published literature.
ASD WORKBENCH
The workbench provides a set of online tools that enable users
to carry out analysis of pre-mRNA sequences. It includes tools
for intron analysis, scoring ATG-context sequence, ﬁnding
exons and identifying splicing regulatory sequences. These
tools are accessed either through a single wrapper interface
or through interfaces that are specialised for individual tools.
Intron analysis
The tool examines intron sequences (as provided by the user)
for putative branch point (BP) sites and polypyrimidine tracts
(PPT). It further calculates the strength of the donor and
acceptor sites. The methods are described elsewhere (10).
The user has a choice of weight matrices for donor and
acceptor sites tailored for different intron types, such as
U2-type GT-AG and GC-AG and U12-type GT-AG and
AT-AC.
Scoring ATG-context sequence
This tool examines each occurrence of ATG in a given tran-
script sequence for its ability to act as translation start codon.
Each ATG is scored for Kozak’s ATG-context sequence (28)
using a weight matrix that we built from experimentally con-
ﬁrmed translation initiation sites. The sequence of translated
peptide from each occurrence of ATG is presented along with
the ATG-context score. FASTA/BLAST searches against
UniProt sequence data can be launched for each of the trans-
lated peptide sequence.
MZEF-SPC exon finder
This tool identiﬁes potential exons in a given nucleotide
sequence. It integrates Michael Zhang’s Exon Finder (29)
and Thanaraj’s SpliceProximalCheck (30). MZEF identiﬁes
putative exons using quadratic discriminant analysis. SPC is
a decision tree implementation of splicing signals that differ-
entiate genuine human splicing sites from the proximal false
sites and thus specialises in validating the predicted exon
boundary for exactness.
Detection of short regulatory sequences
Exons are regulated by short, degenerative sequences that bind
to interacting splicing factors and proteins. These sequences
are collected in the AEdb-Motif database. The Regulatory
Sequence tool uses these motifs to examine a given nucleotide
sequence for their presence. Users have a choice to specify the
extent of allowed mismatches. The identiﬁed motifs are hyper-
linked to the corresponding entries in AEdb-Motif database
(See Figure 4 for illustration of identiﬁed motifs in tra2-beta
gene).Thesplicing rainbow isavisualizations tool thatcolour-
codes presence of different regulatory motifs in a user-
supplied sequence.
SUMMARY OF UPDATES AND ENHANCEMENTS
The current release of ASD includes a large number of
improvements over that reported earlier (9). AltSplice (the
production pipeline) supersedes AltExtron (the research and
development pipeline) in functionalities, data content, integ-
rations and data presentations. As a result, AltExtron has
become redundant and is not maintained any further; however
forarchivalpurposes, theearlierversions ofAltExtrondataare
still presented in ASD web pages. Examples of enhancements
in AltSplice data content include data on evidences for altern-
ative splicing and isoform peptide sequences; those in integ-
rations include related data from UniProt and Ensembl; those
in query tools include differential library expression proﬁler;
and those in presentation of data include a complete redesign
of both the query and data (textual and graphical) results pages
and multiple alignment view of isoform splice pattern and
peptide sequences. In addition to the AEdb-Sequence data
set presented in (9), further AEdb data sets (namely AEdb-
Function, AEdb-Motif and AEdb-Minigenes) are presented.
The ASD workbench is a new addition that complements the
data content. The ASD sequence data are now available for
search through BLAST and FASA tools. The current version
of ASD provides three levels of search facilities, namely
single-query bar, wrapper and data set speciﬁc advanced
search query page. Further, a one-stop query system that
enables users to query many publicly-available databases
(including all the data sets of ASD) on alternative splicing
is now provided. Integrations with splice variant data from
UniProt and Ensembl enhance the value of ASD resources;
AltSplice data are presented on Ensembl genome annotation
browsers as DAS (Distributed Annotation Server) tracks.
Since the last report, the ASD pipeline has matured to high
production standards. The pipeline and the database are now
handled by EBI database-production team which is committed
to making regular data releases, to expanding the repertoire
of organisms for which the data are made available, and to
make seamless integration and hyperlinks both among the
different data sets of ASD and to various other external
databases.
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We present here ASD, a bioinformatics resource for alternat-
ive splicing. The individual components of the resource
are (i) AltSplice—a value-added data set generated by our
AltSplice, (ii) AEdb—a manually curated data set of altern-
atively spliced exons and their properties, and (iii) ASD
Workbench—a collection of tools that carry our various ana-
lyses on pre-mRNA sequences. These individual components
are integrated to one another and to related data from UniProt
and Ensembl. The resource also provides a one-stop query
system that accesses variousotherpubliclyavailable databases
on alternative splicing. The integrated resource is available
to the community (from http://www.ebi.ac.uk/asd) through
user-friendly interfaces. The future releases will contain
data that are being generated by other members of the splicing
community, e.g. array expression data on alternative splicing
of genes.
General enquiries on the ASD database can be mailed at
asd-ebi@ebi.ac.uk.
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